Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mesalazine (Systemic)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Octasa 800mg MR gastro-resistant tablets
0105010B0BIAAAS
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 63,053 |
|
Octasa 400mg MR gastro-resistant tablets
0105010B0BIABAA
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 46,083 |
|
Pentasa 500mg modified-release tablets
0105010B0BCACAI
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 32,055 |
|
Mezavant XL 1200mg tablets
0105010B0BHAAAR
|
Mezavant | Mesalazine (Systemic) | Gastro-Intestinal System | 29,343 |
|
Pentasa 1g modified-release tablets
0105010B0BCAGAY
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 25,265 |
|
Asacol 800mg MR gastro-resistant tablets
0105010B0BBAFAS
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | 17,368 |
|
Mesalazine 1g suppositories
0105010B0AAAJAJ
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 16,631 |
|
Pentasa 2g modified-release granules sachets
0105010B0BCAFAT
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 15,053 |
|
Asacol 400mg MR gastro-resistant tablets
0105010B0BBAAAA
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | 13,645 |
|
Pentasa 1g suppositories
0105010B0BCADAJ
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 12,525 |
|
Salofalk 3g gastro-resistant modified-release gran sachets
0105010B0BDAKAZ
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 12,391 |
|
Pentasa 1g modified-release granules sachets
0105010B0BCAEAN
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 9,037 |
|
Mesalazine 500mg modified-release tablets
0105010B0AAAIAI
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 8,174 |
|
Salofalk 1.5g gastro-resistant modified-release gran sachets
0105010B0BDAHAU
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 7,423 |
|
Mesalazine 1.2g gastro-resistant modified-release tablets
0105010B0AAARAR
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 6,565 |
|
Salofalk 1g suppositories
0105010B0BDAIAJ
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 6,300 |
|
Mesalazine 400mg gastro-resistant tablets
0105010B0AAAAAA
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 6,044 |
|
Octasa 1600mg MR gastro-resistant tablets
0105010B0BIACBD
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 5,962 |
|
Mesalazine 800mg gastro-resistant tablets
0105010B0AAASAS
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 5,589 |
|
Mesalazine 500mg suppositories
0105010B0AAABAB
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 5,196 |
|
Mesalazine 1g/application foam enema
0105010B0AAAKAK
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 4,428 |
|
Salofalk 2g/59ml enema
0105010B0BDADAL
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 3,917 |
|
Salofalk 1g gastro-resistant modified-release gran sachets
0105010B0BDAFAX
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 3,770 |
|
Mesalazine 1g modified-release tablets
0105010B0AAAYAY
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 3,379 |
|
Salofalk 1g/application foam enema
0105010B0BDAEAK
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 2,842 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.